Brooklyn Investment Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.3M Buy
68,560
+22,704
+50% +$1.06M 0.1% 159
2025
Q4
$2.22M Buy
45,856
+33,865
+282% +$1.68M 0.1% 161
2025
Q3
$574K Buy
11,991
+38
+0.3% +$1.83K 0.08% 251
2025
Q2
$577K Buy
11,953
+2,205
+23% +$113K 0.08% 259
2025
Q1
$541K Buy
9,748
+8,113
+496% +$439K 0.12% 168
2024
Q4
$78.9K Buy
1,635
+1,306
+397% +$66.4K 0.02% 414
2024
Q3
$19K Buy
+329
New +$17.8K 0.01% 659

Other funds holding SNY

Brooklyn Investment Group's SNY Position: Q1 2026 in Review

Brooklyn Investment Group increased its Sanofi (SNY) stake by 50% in Q1 2026, buying an estimated $1.06M and bringing the position to 68,560 shares worth $3.3M. The position accounts for 0.1% of the portfolio, ranked #159.

Brooklyn Investment Group first reported a position in SNY in Q3 2024 and has held it in 7 quarters since. 744 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Brooklyn Investment Group held 68,560 shares of Sanofi worth $3.3M as of Q1 2026.
  • Brooklyn Investment Group bought 22,704 Sanofi shares in Q1 2026, an estimated $1.06M.
  • Sanofi made up 0.1% of Brooklyn Investment Group's portfolio in Q1 2026, its #159 holding.
  • Brooklyn Investment Group first reported a position in Sanofi in Q3 2024 and has held it in 7 quarters since.
  • 744 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.